Rapid distribution. Only for short-term treatment in IC. The slow elimination becomes relevant as the length of treatment increases.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Thiopental coma: refractory intracranial hypertension |
|---|
|
| Anaesthesia: induction |
|---|
|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Depression of respiration and cardiac output. Skin reactions because of histamine release. Tissue necrosis on extravasation.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Absolute contraindication: Porphyria.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Watch out for blood pressure drops, reduced resistance, fever and (on prolonged used) impaired liver function.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Halogenated hydrocarbons | ||
|---|---|---|
| N01AB07 | ||
| N01AB06 | ||
| N01AB08 | ||
| Opioid anesthetics | ||
|---|---|---|
| N01AH02 | ||
| N01AH01 | ||
| N01AH06 | ||
| N01AH03 | ||
| Other general anesthetics | ||
|---|---|---|
| N01AX01 | ||
| N01AX14 | ||
| N01AX07 | ||
| N01AX10 | ||
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.